US-based analytical technologies firm, Waters Corporation, is planning to significantly expand its precision chemistry operation in Taunton, Massachusetts (USA). The company anticipates investing approximately $215-mn to build and equip a new state-of-the-art facility that will support rising global customer demand, as well as ongoing innovation in chemistry technology.

The company’s Taunton site is responsible for bulk synthesis of chromatographic media, which is critical to sample analysis for pharmaceutical, biopharmaceutical, materials, food, clinical and biomedical research applications.

“Our portfolio of innovative precision chemistry products is critical to scientific advancements in the life, materials and food sciences. The expansion of our Taunton facility will ensure Waters customers continue to benefit from the most innovative chromatography particle R&D and the highest quality production in the industry,” said Mr. Christopher J. O’Connell, Waters’ Chairman and CEO.

The company said it plans to employ LEED certification standards as well as state-of-the-art manufacturing and process technology to construct a new centre-of-excellence that meets output, cost, quality and sustainability objectives. The new plant is likely to be operational by 2022. Until then, the existing Taunton facility will fully meet operational and growth needs, the company added.